800 Participants Needed

Telehealth Interventions for Caregiver Well-being

(WellCAST Trial)

BL
Overseen ByBridgette L Kelleher, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Purdue University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you are actively in treatment that overlaps with the trial's offerings, you may not be eligible to participate.

What data supports the effectiveness of the treatment Telehealth Interventions for Caregiver Well-being?

Research shows that culturally adapted cognitive behavioral therapy (CBT) can be effective for Chinese clients by aligning with their cultural values, suggesting that similar adaptations in telehealth interventions could enhance caregiver well-being.12345

Is Acceptance and Commitment Therapy (ACT) safe for caregivers?

Research on Acceptance and Commitment Therapy (ACT) for caregivers, including those caring for people with dementia, suggests it is generally safe. Studies have shown that both face-to-face and online versions of ACT are effective and do not report any significant safety concerns.678910

How is the Telehealth Interventions for Caregiver Well-being treatment different from other treatments for caregiver support?

This treatment is unique because it uses telehealth to deliver various evidence-based therapies like ACT, CICBT, and DBT remotely, making it more accessible and convenient for caregivers who may face geographical or logistical barriers to in-person therapy. The use of telehealth allows for flexible, culturally informed, and self-guided interventions that have been shown to improve caregiver well-being and reduce problem behaviors in care recipients.1011121314

What is the purpose of this trial?

The goal of this clinical trial is to learn which types of telehealth-based treatments best fit the needs of caregivers of people with rare neurogenetic conditions. The main questions it plans to answer are:* Which telehealth support programs best meet the needs of rare disorder caregivers?* How can individuals be matched to support programs that are right for them? What aspects of an individual (e.g., demographics, mental health symptoms, family characteristics, lifestyle) predict whether treatment will be a good fit?* Does peer-to-peer coaching help improve patients' experiences during telehealth treatment?Participants will be asked to complete a 12-week treatment program, which may include self-guided resources, individual therapies, group therapies, and/or peer-to-peer coaching.Before, during, and after treatment, participants will complete questionnaires to help researchers understand their experiences, symptoms, and impressions of their support program. Questionnaires will include both standard forms (administered up to 5 times throughout the study) and brief "snapshot surveys" that participants complete on their smartphones up to 3 times per day.Some participants will be assigned to a waitlist control, which means that they will provide data while they are not yet completing a support program. These participants will be assigned to a support program in the next treatment phase.

Research Team

BK

Bridgette Kelleher, PhD

Principal Investigator

Purdue University

Eligibility Criteria

This trial is for caregivers and legal guardians of children aged 2-35 with neurogenetic conditions that cause moderate to severe intellectual disability. Participants must live in the US, be fluent in English, and seek support for their mental health or caregiving needs.

Inclusion Criteria

Reside in US
Fluent in English (spoken and written)
I am looking for mental health or caregiving support.
See 2 more

Exclusion Criteria

Serious mental illness or active addiction that would be inadequately addressed through dosage of treatments
Actively in treatment that would be redundant with those offered in the protocol
Child's syndrome is not commonly associated with life expectancy less than 35 years or deterioration of previously gained skills

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
1 visit (virtual)

Baseline

Caregivers complete initial study forms and 'snapshot surveys' sent three times per day via smartphones

2 weeks
Daily virtual surveys

Treatment

Participants complete a 12-week telehealth support program, which may include self-guided resources, individual therapies, group therapies, and/or peer-to-peer coaching

12 weeks
3 daily virtual surveys, periodic study forms

Follow-up

Participants complete follow-up forms and a 2-week period of 'snapshot surveys' to assess changes post-treatment

2 weeks
Daily virtual surveys

Treatment Details

Interventions

  • Acceptance and Commitment Therapy (ACT)
  • Culturally Informed Cognitive Behavioral Therapy (CICBT)
  • Dialectical Behavioral Therapy (DBT)
  • Durand Sleep Intervention
  • Naturalistic Communication Intervention (NCI)
  • Participation Enhancement Intervention (PEI)
  • RUBI Intervention
  • Self-Guided Resources
Trial Overview The study tests various telehealth-based treatments like individual/group therapies and peer coaching to see which best supports caregivers of people with rare disorders. It involves a 12-week program with questionnaires before, during, after treatment, plus daily surveys on smartphones.
Participant Groups
9Treatment groups
Experimental Treatment
Active Control
Group I: No Algorithm + Participation Enhancement InterventionExperimental Treatment9 Interventions
Participants are randomly assigned to support program without use of a personalized health algorithm AND receive the participation enhancement intervention.
Group II: No Algorithm + No Participation Enhancement InterventionExperimental Treatment8 Interventions
Participants are randomly assigned to support program without use of a personalized health algorithm AND do not receive the participation enhancement intervention.
Group III: Algorithm 3 + Participation Enhancement InterventionExperimental Treatment9 Interventions
Participants are assigned to support programs using Algorithm 3 AND receive the participation enhancement intervention.
Group IV: Algorithm 3 + No Participation Enhancement InterventionExperimental Treatment8 Interventions
Participants are assigned to support programs using Algorithm 3 AND do not receive the participation enhancement intervention.
Group V: Algorithm 2 + Participation Enhancement InterventionExperimental Treatment9 Interventions
Participants are assigned to support programs using Algorithm 2 AND receive the participation enhancement intervention.
Group VI: Algorithm 2 + No Participation Enhancement InterventionExperimental Treatment8 Interventions
Participants are assigned to support programs using Algorithm 2 AND do not receive the participation enhancement intervention.
Group VII: Algorithm 1 + Participation Enhancement InterventionExperimental Treatment9 Interventions
Participants are assigned to support programs using Algorithm 1 AND receive the participation enhancement intervention.
Group VIII: Algorithm 1 + No Participation Enhancement InterventionExperimental Treatment8 Interventions
Participants are assigned to support programs using Algorithm 1 AND do not receive the participation enhancement intervention.
Group IX: Waitlist ControlActive Control1 Intervention
Participants are enrolled in the waitlist control condition, which includes identical data collection procedures to participants enrolled in support programs. Waitlist controls are offered the opportunity to enroll in future cycles.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Purdue University

Lead Sponsor

Trials
239
Recruited
72,200+

University of Virginia

Collaborator

Trials
802
Recruited
1,342,000+

University of Canterbury

Collaborator

Trials
4
Recruited
840+

University of Oregon

Collaborator

Trials
91
Recruited
46,700+

Georgia State University

Collaborator

Trials
71
Recruited
33,600+

University of Missouri-Columbia

Collaborator

Trials
387
Recruited
629,000+

Indiana University

Collaborator

Trials
1,063
Recruited
1,182,000+

Findings from Research

The study involved 15 mental health professionals who provided feedback on the cultural and linguistic adaptation of Meaning-Centered Psychotherapy for Chinese patients with advanced cancer, indicating high acceptability and relevance across various domains.
Recommendations for improving the intervention include enhancing flexibility for tailoring content to individual patient needs, simplifying the material for better comprehension, and providing additional training for providers to ensure effective implementation in real-world settings.
Refinement of a Meaning-Centered Counseling Program for Chinese Patients with Advanced Cancer: Integrating Cultural Adaptation and Implementation Science Approaches.Lui, F., Zhang, Q., Bao, G., et al.[2023]
Cognitive Behaviour Therapy (CBT) shows a strong compatibility with core values of Chinese culture, suggesting it can be effectively used without needing to create entirely new therapies.
Chinese clients may particularly benefit from CBT by challenging irrational beliefs tied to social norms, indicating that minor adjustments to CBT could enhance its effectiveness in this cultural context.
Would Confucius benefit from psychotherapy? The compatibility of cognitive behaviour therapy and Chinese values.Hodges, J., Oei, TP.[2022]
A study involving 70 mental health professionals and 54 Latino patients with advanced cancer showed that culturally and linguistically adapted meaning-centered psychotherapy is highly acceptable and relevant for this population.
Qualitative interviews with 24 Latino patients highlighted the importance of simplifying language, using culturally relevant metaphors, and ensuring that the intervention aligns with Latino cultural values to improve psychological adjustment and well-being.
Meaning-Centered Psychotherapy for Latino Patients with Advanced Cancer: Cultural Adaptation Process.Costas-Muñiz, R., Torres-Blasco, N., Castro-Figueroa, EM., et al.[2021]

References

Refinement of a Meaning-Centered Counseling Program for Chinese Patients with Advanced Cancer: Integrating Cultural Adaptation and Implementation Science Approaches. [2023]
Would Confucius benefit from psychotherapy? The compatibility of cognitive behaviour therapy and Chinese values. [2022]
Meaning-Centered Psychotherapy for Latino Patients with Advanced Cancer: Cultural Adaptation Process. [2021]
American Indian cultures: how CBPR illuminated intertribal cultural elements fundamental to an adaptation effort. [2022]
Engaging Turkish Immigrants in Psychotherapy: Development and Proof-of-Concept Study of a Culture-Tailored, Web-Based Intervention. [2023]
Internet-delivered guided self-help acceptance and commitment therapy for family carers of people with dementia (iACT4CARERS): a feasibility study. [2023]
Patient and health care professional co-development of an Acceptance and Commitment Therapy intervention to support hormone therapy decision-making and well-being in women with breast cancer. [2022]
Comparison of motivational interviewing with acceptance and commitment therapy: a conceptual and clinical review. [2021]
Cognitive-behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for dementia family caregivers with significant depressive symptoms: Results of a randomized clinical trial. [2018]
Outcomes from a pilot online Acceptance and Commitment Therapy program for dementia family caregivers. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Outcomes and Acceptability of Telehealth-Based Coaching for Caregivers in Asian Countries. [2023]
A systematic review of telehealth tools and interventions to support family caregivers. [2018]
13.United Statespubmed.ncbi.nlm.nih.gov
Feasibility, usability, and acceptability of psychoeducational videoconferencing interventions for informal caregivers: A systematic review of randomized controlled trials. [2023]
14.United Statespubmed.ncbi.nlm.nih.gov
Supporting Caregivers Remotely During a Pandemic: Comparison of WHO Caregiver Skills Training Delivered Online Versus in Person in Public Health Settings in Italy. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security